Lazarus J H, Ammari F, Oretti R, Parkes A B, Richards C J, Harris B
Department of Medicine, University of Wales College of Medicine, Cardiff.
Br J Gen Pract. 1997 May;47(418):305-8.
Postpartum thyroiditis (PPT), characterized by transient hyperthyroidism and transient hypothyroidism, occurs in 5-9% of women. It is accompanied by the presence of circulating antithyroid peroxidase antibodies (TPOAb) which have been associated with an increase in depressive symptomatology compared with TPOAb-negative women.
To assess the frequency and nature of the syndrome in patients studied in detail after more than one pregnancy, as there are only sparse data on recurrence of PPT.
Fifty-four patients were identified who had participated in at least two of three detailed postpartum studies of thyroid and psychiatric function during the past 12 years in the Caerphilly and Cardiff regions of South Wales. They included two women who had had three pregnancies. All patients had been followed monthly postpartum for at least six months, and 44 had been followed for 12 months.
Of the 13 patients who developed PPT after their first pregnancy, nine had a recurrence of dysfunction after a further pregnancy and four remained TPOAb positive. Of the 24 women who were euthyroid anti-TPO positive after the first pregnancy, six developed thyroid dysfunction after a subsequent delivery, 14 remained antibody positive and euthyroid, while four underwent seroconversion and were antibody negative. The control group of 17 women were antibody negative after the first pregnancy; 16 remained negative after a further pregnancy and one became anti-TPO positive. The severity of PPT was slightly, but not significantly worse after the second recorded pregnancy (67% hypothyroid versus 44% hypothyroid). Neither the maximum anti-TPO titre following the first pregnancy, nor the rise in titre during this period were predictive of outcome after a subsequent pregnancy. Data from 26 women showed that recurrent depression was seen in 15.4%; a further six were depressed after the first pregnancy only, and two during a further postpartum period.
There was a 70% chance of developing recurrent PPT after a first attack, and a 25% risk even in women who were only anti-TPO positive without thyroid dysfunction during the first postpartum period. The recurrence of postpartum depression was not related to thyroid function. Patients noted to have thyroid dysfunction or just to be euthyroid but anti-TPO positive after pregnancy should be assessed carefully after a subsequent pregnancy.
产后甲状腺炎(PPT)的特征为短暂性甲状腺功能亢进和短暂性甲状腺功能减退,在5% - 9%的女性中发生。其伴有循环抗甲状腺过氧化物酶抗体(TPOAb)的存在,与TPOAb阴性女性相比,这些抗体与抑郁症状的增加有关。
评估在经历不止一次妊娠后详细研究的患者中该综合征的发生频率和性质,因为关于产后甲状腺炎复发的数据稀少。
确定了54名患者,他们在过去12年中参与了南威尔士卡菲利和加的夫地区关于甲状腺和精神功能的三项详细产后研究中的至少两项。其中包括两名有三次妊娠经历的女性。所有患者产后每月随访至少六个月,44名患者随访了12个月。
在首次妊娠后发生产后甲状腺炎的13名患者中,9名在再次妊娠后出现功能复发,4名仍为TPOAb阳性。在首次妊娠后甲状腺功能正常但抗TPO阳性的24名女性中,6名在随后分娩后出现甲状腺功能障碍,14名仍为抗体阳性且甲状腺功能正常,而4名发生血清学转换且抗体阴性。17名女性的对照组在首次妊娠后抗体阴性;再次妊娠后16名仍为阴性,1名变为抗TPO阳性。在第二次记录的妊娠后,产后甲状腺炎的严重程度略有增加,但无显著差异(甲状腺功能减退者从44%增至67%)。首次妊娠后的最高抗TPO滴度以及在此期间滴度的升高均不能预测随后妊娠的结局。26名女性的数据显示,15.4%出现复发性抑郁;另有6名仅在首次妊娠后抑郁,2名在另一次产后期间抑郁。
首次发作后发生产后甲状腺炎复发的几率为70%,即使在首次产后期间仅抗TPO阳性而无甲状腺功能障碍的女性中,复发风险也为25%。产后抑郁的复发与甲状腺功能无关。在随后妊娠后,对妊娠后出现甲状腺功能障碍或仅甲状腺功能正常但抗TPO阳性的患者应进行仔细评估。